Claris O, Salle B L
Department of Neonatology, Hôpital Edouard Herriot, Lyon, France.
Acta Paediatr. 1997 Apr;86(4):339-41. doi: 10.1111/j.1651-2227.1997.tb09018.x.
Surfactant therapy has become widely used in neonates suffering from respiratory distress syndrome. High frequency oscillation has been shown to be efficient and safe in animal models, but somewhat less convincing in human neonates. An overview is given of the experimental and clinical data assessing the combination of these two techniques. Personal preliminary data are briefly presented.
表面活性剂疗法已广泛应用于患有呼吸窘迫综合征的新生儿。高频振荡在动物模型中已被证明是有效且安全的,但在人类新生儿中效果稍欠说服力。本文概述了评估这两种技术联合应用的实验和临床数据,并简要介绍了个人的初步数据。